CDC15 Antibody

What is CDC15 and what cellular functions does it regulate?

CDC15 is a multifunctional protein with distinct roles depending on the organism. In Schizosaccharomyces pombe (fission yeast), CDC15 functions as an F-BAR protein essential for cytokinesis by attaching the cytokinetic ring to the plasma membrane . Its membrane binding ability is regulated through phosphorylation of its intrinsically disordered region (IDR). In budding yeast, CDC15 serves as a kinase in the Mitotic Exit Network (MEN) and phosphorylates Ser-2 and Ser-5 of RNA Polymerase II's C-terminal domain during mitosis . Additionally, CDC15 plays roles in spore morphogenesis independently of its mitotic exit functions .

How does CDC15 phosphorylation affect its cellular localization and function?

CDC15 phosphorylation regulates its subcellular localization and function through a threshold-dependent mechanism. Multiple kinases including Pom1, Kin1, Pck1, and Shk1 phosphorylate distinct but overlapping sites within CDC15's intrinsically disordered region . Increased phosphorylation inhibits CDC15's membrane association by masking positively charged amino acids necessary for F-BAR oligomerization and membrane interaction. Experiments with phosphomutants demonstrate that membrane localization increases with the number of phosphosites mutated to alanine, with significant jumps between 11A and 22A mutants . This phosphoregulation prevents premature cytokinetic ring assembly at inappropriate cellular locations.

What are the key differences between CDC15 antibody applications in different yeast species?

When working with CDC15 antibodies across different yeast species, researchers must consider:

What is the optimal Western blot protocol for detecting CDC15 and its phosphoforms?

For optimal detection of CDC15 and its various phosphorylation states, follow this validated protocol:

• Resolve proteins in freshly poured (within 24 hours) 8% Tris-glycine gels run at 150V for 2.25 hours, or pre-poured NuPAGE 3-8% Tris-Acetate gels run at 150V for 2.15 hours .

• Transfer proteins to PVDF membrane (Immobilon FL) for 2 hours.

• Block with appropriate buffer (typically 5% non-fat milk or BSA in TBST).

• Incubate with anti-CDC15 polyclonal antibody (such as VU326) at recommended dilution.

• Wash extensively with TBST.

• Incubate with secondary antibodies conjugated to IRDye 680 or IRDye 800.

• Visualize using an Odyssey instrument.

For phosphorylation-specific analysis, include appropriate phosphatase inhibitors in lysis buffers and consider lambda phosphatase treatment as a control .

What is the recommended protocol for CDC15 immunoprecipitation in yeast cells?

For successful CDC15 immunoprecipitation from yeast cells:

• Prepare protein extracts from cells in B70 buffer with protease inhibitors (Complete X, Roche) .

• For tagged CDC15 (e.g., CDC15-HA), use 1mg of protein extract with μMACS-HA isolation kit (Miltenyi Biotec).

• For native CDC15, use anti-CDC15 polyclonal antibody (like VU326) for 1 hour at 4°C followed by protein A sepharose incubation for 30 minutes .

• Wash immunoprecipitates thoroughly (twice with extraction buffer, twice with appropriate secondary buffer).

• For phosphatase assays, incubate washed beads with lambda protein phosphatase according to manufacturer's protocol .

• Elute proteins by boiling in SDS sample buffer and analyze by immunoblotting.

How can researchers perform effective immunofluorescence for CDC15 localization studies?

For high-quality immunofluorescence detection of CDC15:

• Fix cells using appropriate fixative (typically formaldehyde).

• Permeabilize cells to allow antibody access.

• Block with PBS-BSA 1%.

• Apply primary antibodies at 1:100 dilution and incubate for 1 hour.

• Wash five times with PBS-BSA 1%.

• Incubate with secondary antibodies (1:200) for 1 hour .

• Wash thoroughly with PBS buffer.

• Mount samples with DAPI-containing mounting media.

• Image using fluorescence microscopy, confocal microscopy, or super-resolution techniques depending on research questions.

Secondary antibodies coupled to Alexa Fluor 488, 594, or 633 have been validated for CDC15 detection .

How can researchers distinguish between different CDC15 phosphospecies in experimental samples?

Distinguishing CDC15 phosphospecies requires specialized approaches:

• Gel Selection: Use freshly poured 8% Tris-glycine gels or pre-poured NuPAGE 3–8% Tris-Acetate gels for optimal separation of phosphospecies .

• Controls: Include lambda phosphatase-treated samples as dephosphorylation controls.

• Phosphomutants: Compare wild-type CDC15 with phosphomutants (e.g., CDC15-11A, CDC15-22A, CDC15-31A) to identify migration patterns of specific phosphoforms .

• Kinase Inhibition: Use analog-sensitive kinase strains with specific inhibitors (e.g., CDC15-as1 with 1-NAPP1) or temperature-sensitive mutants to identify kinase-specific phosphorylation patterns .

The mobility shift pattern correlates with phosphorylation status, with higher phosphorylation resulting in slower migration.

What are common pitfalls in CDC15 antibody experiments and how can they be addressed?

Researchers should be aware of these common challenges when working with CDC15 antibodies:

How should researchers interpret changes in CDC15 phosphorylation during cell cycle progression?

When analyzing CDC15 phosphorylation across the cell cycle:

• Mitotic Exit Network Activation: In budding yeast, CDC15 activity increases during mitotic exit. Temperature-sensitive CDC15 mutants (CDC15-2) show reduced Ser-5 and Ser-2 phosphorylation of RNA Pol II CTD during mitotic arrest .

• Membrane Localization: Higher CDC15 phosphorylation correlates with reduced membrane localization. The ratio of plasma membrane to cytoplasmic localization decreases with increasing phosphorylation .

• Cytokinetic Ring Formation: Dephosphorylated CDC15 forms condensates at the plasma membrane that recruit other cytokinetic ring components .

• Recovery Patterns: After release from arrest, cells typically regain their normal CDC15 phosphorylation state, indicating reversibility of the phosphoregulation mechanism .

How can CDC15 antibodies be used to study liquid-liquid phase separation and protein condensates?

CDC15 has been shown to undergo liquid-liquid phase separation (LLPS) when dephosphorylated, forming droplets that recruit binding partners . For studying this phenomenon:

• In vitro studies: Use purified recombinant CDC15 with specific antibodies to track phase separation under controlled conditions.

• Phosphorylation analysis: Compare wild-type CDC15 with phosphomutants (e.g., 31A) to demonstrate the relationship between phosphorylation state and condensate formation.

• Colocalization studies: Use CDC15 antibodies in combination with antibodies against known binding partners to analyze recruitment to condensates.

• Dynamics assessment: Track the formation, fusion, and dissolution of CDC15 condensates using live-cell imaging validated by fixed-cell immunofluorescence.

Research has demonstrated that CDC15 cortical condensates recruit other cytokinetic ring components and exhibit liquid-like properties including fusion and fission events .

What approaches enable researchers to study CDC15 kinase activity and its substrates?

To investigate CDC15 kinase activity and substrate relationships:

• Analog-sensitive mutants: Utilize CDC15-as1 (L99G) strains with specific inhibitors like 1-NAPP1 to selectively inhibit CDC15 kinase activity .

• Temperature-sensitive alleles: Use CDC15-2 or CDC15-1 temperature-sensitive mutants to conditionally inactivate CDC15 and observe effects on substrate phosphorylation .

• Phospho-specific antibodies: Develop or obtain antibodies against known CDC15 substrates (e.g., Nud1-T78) to directly measure kinase activity .

• Live-cell reporters: Implement fluorescent reporters that change localization upon phosphorylation by CDC15 or its downstream effectors, such as the NLS-CDC14 reporter system .

How can CDC15 antibodies contribute to understanding the regulation of cytokinesis across different model systems?

CDC15 plays crucial roles in cytokinesis that can be studied using antibody-based approaches:

• Comparative analysis: Use CDC15 antibodies to study differences in localization and phosphorylation patterns between fission yeast, budding yeast, and potentially higher eukaryotes.

• Regulatory mechanisms: Employ phospho-specific antibodies to track how multiple kinases (Pom1, Kin1, Pck1, Shk1) regulate CDC15 during cytokinesis .

• Interaction studies: Combine CDC15 immunoprecipitation with mass spectrometry to identify binding partners and regulators across different systems.

• Super-resolution imaging: Apply CDC15 antibodies in super-resolution microscopy to resolve node-like structures observed within the cytokinetic ring .

How can CDC15 antibodies be integrated with genomic and proteomic approaches for systems-level analysis?

Modern systems biology approaches can be enhanced with CDC15 antibodies:

• ChIP-seq applications: Use CDC15 antibodies for chromatin immunoprecipitation followed by sequencing to identify genomic regions associated with CDC15, particularly relevant given its role in RNA Polymerase II regulation .

• Phosphoproteomics: Combine CDC15 kinase manipulations (inhibition, mutation) with global phosphoproteomic analysis to identify direct and indirect substrates.

• Proximity labeling: Employ CDC15 antibodies to validate results from BioID or APEX2 proximity labeling studies identifying proteins in the CDC15 interaction network.

• Spatial proteomics: Integrate CDC15 immunofluorescence with multiplexed protein detection methods to create spatial maps of protein interactions during cytokinesis and mitotic exit.

What considerations are important when selecting CDC15 antibodies for specialized applications beyond standard techniques?

For specialized research applications, consider these critical factors: